Literature DB >> 1678810

Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards.

Y Matsubara1, K Narisawa, K Tada, H Ikeda, Y Q Yao, D M Danks, A Green, E R McCabe.   

Abstract

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is an autosomal recessive disorder that has been associated with sudden infant death syndrome and a condition resembling Reye's syndrome. The point mutation K329E is thought to be the commonest mutation causing MCAD deficiency in caucasian patients. The prevalence of this mutation was determined by use of dried blood spots on Guthrie cards obtained during neonatal screening programmes. 12 carriers were identified among 479 newborn babies in Britain, 5 among 353 in Australia, and 5 among 536 in North America but none among 500 in Japan. Since presymptomatic diagnosis and appropriate dietary management can prevent life-threatening episodes in MCAD deficiency, population-based DNA screening for this potentially fatal disorder might be justified in countries with a high frequency of this mutation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678810     DOI: 10.1016/0140-6736(91)91110-g

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Measurement of acyl-CoA dehydrogenase activity in cultured skin fibroblasts and blood platelets.

Authors:  R W Taylor; S Jackson; M Pourfarzam; K Bartlett; D M Turnbull
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Inherited metabolic diseases in the sudden infant death syndrome.

Authors:  L J Smith
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

3.  The frequency of MCAD mutation (K329E) in the Finnish population.

Authors:  E I Schwartz; J Ilonen; N A Skobeleva; H K Akerblom
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

Review 4.  L-Carnitine.

Authors:  J H Walter
Journal:  Arch Dis Child       Date:  1996-06       Impact factor: 3.791

5.  The frequency of medium-chain acyl-CoA dehydrogenase G985 mutation in the Hungarian population.

Authors:  C Szalai; A Czinner; K Revai
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

6.  Molecular genetic characterization and urinary excretion pattern of metabolites in two families with MCAD deficiency due to compound heterozygosity with a 13 base pair insertion in one allele.

Authors:  N Gregersen; V Winter; S Lyonnet; J M Saudubray; U Wendel; T G Jensen; B S Andresen; S Kølvraa; W Lehnert; L Bolund
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

7.  Medium-chain acyl-CoA dehydrogenase deficiency does not correlate with apparent life-threatening events and the sudden infant death syndrome: results from phenylpropionate loading tests and DNA analysis.

Authors:  J M Penzien; G Molz; U N Wiesmann; J P Colombo; R Bühlmann; B Wermuth
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

8.  Rapid detection of medium chain acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels.

Authors:  A Iolascon; T Parrella; S Perrotta; O Guardamagna; P M Coates; M Sartore; S Surrey; P Fortina
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

9.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

10.  Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.

Authors:  P T Clayton; M Doig; S Ghafari; C Meaney; C Taylor; J V Leonard; M Morris; A W Johnson
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.